Orphenadrine EP Impurity E

Development of a capillary electrophoresis method for the determination of orphenadrine citrate in tablets in the presence of paracetamol
Dana N.Haj-Ali, Imad I.Hamdan
Saudi Pharmaceutical Journal Volume 18, Issue 4, October 2010, Pages 233-237
 
A Validated Chiral Liquid Chromatographic Method for the Enantiomeric Separation of Orphenadrine Citrate in Pharmaceutical Dosage Form
Ramachandran S. Kumar, Subramania N. Meyyanathan, Byran Gowramma
Current Pharmaceutical Analysis Volume 12 , Issue 4 , 2016
 
Development and Validation of Chromatographic Methods for Simultaneous Determination of Paracetamol, Orphenadrine Citrate and Caffeine in Presence of P-aminophenol; Quantification of P-aminophenol Nephrotoxic Impurity Using LC–MS/MS
Shereen A Boltia, Aya T Soudi, Eman S Elzanfaly, Hala E Zaazaa
Journal of Chromatographic Science, Volume 58, Issue 3, March 2020, Pages 223–233

Orphenadrine EP Impurity E is chemically (RS)-N,N-Dimethyl-2-[(3-methylphenyl)phenylmethoxy]ethanamine (as per EP). It is also known as Meta-methylbenzyl isomer ; Orphenadrine USP Related Compound E. Orphenadrine EP Impurity E is supplied with detailed characterization data compliant with regulatory guideline. Orphenadrine EP Impurity E can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Orphenadrine.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.